Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
503.50 SEK | +2.21% |
|
+11.79% | +26.06% |
Feb. 07 | Handelsbanken Fonder reduces its ownership in Mycronic | FW |
Feb. 07 | Handelsbanken Fonder reduces its ownership in Mycronic | FW |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.31B | 3.88B | 4.64B | 5.12B | 5.71B | |||||
Total Revenues | 4.31B | 3.88B | 4.64B | 5.12B | 5.71B | |||||
Cost of Goods Sold, Total | 1.91B | 1.8B | 2.32B | 2.83B | 2.85B | |||||
Gross Profit | 2.4B | 2.08B | 2.31B | 2.29B | 2.86B | |||||
Selling General & Admin Expenses, Total | 778M | 671M | 769M | 889M | 996M | |||||
R&D Expenses | 559M | 496M | 548M | 638M | 653M | |||||
Other Operating Expenses | -33M | -37M | -55M | -98M | -44M | |||||
Other Operating Expenses, Total | 1.3B | 1.13B | 1.26B | 1.43B | 1.6B | |||||
Operating Income | 1.1B | 950M | 1.05B | 859M | 1.25B | |||||
Interest Expense, Total | -11M | -14M | -14M | -13M | -13M | |||||
Interest And Investment Income | 9M | 6M | 11M | 9M | 40M | |||||
Net Interest Expenses | -2M | -8M | -3M | -4M | 27M | |||||
Currency Exchange Gains (Loss) | -8M | -34M | 27M | 12M | -16M | |||||
Other Non Operating Income (Expenses) | - | 1M | - | 1M | - | |||||
EBT, Excl. Unusual Items | 1.08B | 909M | 1.08B | 868M | 1.26B | |||||
Merger & Related Restructuring Charges | - | -18M | -30M | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | 23M | - | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | 37M | - | - | - | - | |||||
EBT, Incl. Unusual Items | 1.12B | 891M | 1.05B | 891M | 1.26B | |||||
Income Tax Expense | 263M | 187M | 219M | 154M | 266M | |||||
Earnings From Continuing Operations | 859M | 704M | 827M | 737M | 996M | |||||
Net Income to Company | 859M | 704M | 827M | 737M | 996M | |||||
Minority Interest | -4M | -10M | 1M | 4M | 2M | |||||
Net Income - (IS) | 855M | 694M | 828M | 741M | 998M | |||||
Net Income to Common Incl Extra Items | 855M | 694M | 828M | 741M | 998M | |||||
Net Income to Common Excl. Extra Items | 855M | 694M | 828M | 741M | 998M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 8.73 | 7.1 | 8.48 | 7.59 | 10.22 | |||||
Basic EPS - Continuing Operations | 8.73 | 7.1 | 8.48 | 7.59 | 10.22 | |||||
Basic Weighted Average Shares Outstanding | 97.89M | 97.74M | 97.65M | 97.6M | 97.61M | |||||
Net EPS - Diluted | 8.73 | 7.1 | 8.48 | 7.59 | 10.22 | |||||
Diluted EPS - Continuing Operations | 8.73 | 7.1 | 8.48 | 7.59 | 10.22 | |||||
Diluted Weighted Average Shares Outstanding | 97.9M | 97.76M | 97.71M | 97.61M | 97.64M | |||||
Normalized Basic EPS | 6.89 | 5.71 | 6.9 | 5.6 | 8.1 | |||||
Normalized Diluted EPS | 6.89 | 5.71 | 6.89 | 5.6 | 8.1 | |||||
Dividend Per Share | 2 | 3 | 3 | 3.5 | 4.5 | |||||
Payout Ratio | 34.39 | 28.24 | 35.51 | 39.68 | 34.37 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.21B | 1.04B | 1.13B | 994M | 1.39B | |||||
EBITA | 1.18B | 995M | 1.07B | 932M | 1.31B | |||||
EBIT | 1.1B | 950M | 1.05B | 859M | 1.25B | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 23.44 | 20.99 | 20.94 | 17.28 | 21.08 | |||||
Total Current Taxes | 217M | 188M | 188M | 196M | 251M | |||||
Total Deferred Taxes | 45M | -1M | 31M | -42M | 15M | |||||
Normalized Net Income | 674M | 558M | 674M | 546M | 791M | |||||
Interest on Long-Term Debt | 2M | 5M | 5M | 5M | 6M | |||||
Non-Cash Pension Expense | 500K | 400K | 100K | -200K | -1.3M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 541M | 435M | 526M | 611M | 658M | |||||
General and Administrative Expenses | 237M | 236M | 243M | 278M | 338M | |||||
Research And Development Expense From Footnotes | 559M | 514M | 548M | 638M | 653M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 1.37M | 2.44M | - | - | 3.3M | |||||
Total Stock-Based Compensation | 1.37M | 2.44M | - | - | 3.3M |